APP and APLP2 interact with the synaptic release machinery and facilitate transmitter release at hippocampal synapses

eLife

Volumn 4, Issue NOVEMBER2015, 2015, Pages

  Fanutza, Tomas ^a   del Prete, Dolores ^a   Ford, Michael J ^b   Castillo, Pablo E ^a   D’Adamio, Luciano ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MS BIOWORKS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; AMYLOID PRECURSOR PROTEIN LIKE PROTEIN 2; UNCLASSIFIED DRUG; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; APLP2 PROTEIN, MOUSE; PROTEIN BINDING;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CONTROLLED STUDY; EXCITATORY POSTSYNAPTIC POTENTIAL; FEMALE; HIPPOCAMPAL CA1 REGION; IMMUNOFLUORESCENCE; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MOUSE; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; PROTEIN PROTEIN INTERACTION; SYNAPSE; WHOLE CELL PATCH CLAMP; ANIMAL; C57BL MOUSE; GENE DELETION; GENETICS; HIPPOCAMPUS; METABOLISM; PHYSIOLOGY; PROTEIN ANALYSIS; SYNAPTIC TRANSMISSION;

AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; GENE DELETION; HIPPOCAMPUS; MICE, INBRED C57BL; NEUROTRANSMITTER AGENTS; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; SYNAPSES; SYNAPTIC TRANSMISSION;

EID: 84957900258     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.09743     Document Type: Article

References (103)

1. Annaert WIM, Cupers P, Saftig P, Strooper B. 2000. Presenilin function in APP processing. Annals of the New York Academy of Sciences 920:158-164. doi: 10.1111/j.1749-6632.2000.tb06917.x.
2. Baek SH, Ohgi KA, Rose DW, Koo EH, Glass CK, Rosenfeld MG. 2002. Exchange of n-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-kappaB and beta-amyloid precursor protein. Cell 110:55-67. doi: 10.1016/S0092-8674(02)00809-7.
3. Barbagallo APM, Wang Z, Zheng H, D’Adamio L, Ginsberg S. 2011a. The intracellular threonine of amyloid precursor protein that is essential for docking of Pin1 is dispensable for developmental function. PLoS ONE 6:e18006. doi: 10.1371/journal.pone.0018006.
4. Barbagallo APM, Wang Z, Zheng H, D’Adamio L. 2011b. A single tyrosine residue in the amyloid precursor protein intracellular domain is essential for developmental function. Journal of Biological Chemistry 286:8717-8721. doi: 10.1074/jbc.C111.219873.
5. Bertrand E, Brouillet E, Caillé I, Bouillot C, Cole GM, Prochiantz A, Allinquant B. 2001. A short cytoplasmic domain of the amyloid precursor protein induces apoptosis in vitro and in vivo. Molecular and Cellular Neuroscience 18:503-511. doi: 10.1006/mcne.2001.1030.
6. Cao X, Südhof TC. 2001. A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 293:115-120. doi: 10.1126/science.1058783.
7. Checler F, Sunyach C, Pardossi-Piquard R, Sevalle J, Vincent B, Kawarai T, Girardot N, George-Hyslop PS, da Costa C. 2007. The gamma/epsilon-secretase-derived APP intracellular domain fragments regulate p53. Current Alzheimer Research 4:423-426. doi: 10.2174/156720507781788945.
8. CisséM, Halabisky B, Harris J, Devidze N, Dubal DB, Sun B, Orr A, Lotz G, Kim DH, Hamto P, Ho K, Yu GQ, Mucke L. 2011. Reversing EphB2 depletion rescues cognitive functions in alzheimer model. Nature 469:47-52.doi: 10.1038/nature09635.
9. Cupers P, Orlans I, Craessaerts K, Annaert W, De Strooper B. 2001. The amyloid precursor protein (aPP)- cytoplasmic fragment generated by g-secretase is rapidly degraded but distributes partially in a nuclear fraction of neurones in culture. Journal of Neurochemistry 78:1168-1178. doi: 10.1046/j.1471-4159.2001.00516.x.
10. Davidson TJ, Harel S, Arboleda VA, Prunell GF, Shelanski ML, Greene LA, Troy CM. 2004. Highly efficient small interfering RNA delivery to primary mammalian neurons induces MicroRNA-like effects before mRNA degradation. The Journal of Neuroscience 24:10040-10046. doi: 10.1523/JNEUROSCI.3643-04.2004.
11. Dawson GR, Seabrook GR, Zheng H, Smith DW, Graham S, O’Dowd G, Bowery BJ, Boyce S, Trumbauer ME, Chen HY, Van der Ploeg LHT, Sirinathsinghji DJS. 1999. Age-related cognitive deficits, impaired long-term potentiation and reduction in synaptic marker density in mice lacking the beta-amyloid precursor protein. Neuroscience 90:1-13. doi: 10.1016/S0306-4522(98)00410-2.
12. De Strooper B. 2003. Aph-1, pen-2, and nicastrin with presenilin generate an active g-secretase complex. Neuron 38:9-12. doi: 10.1016/S0896-6273(03)00205-8.
13. De Strooper B. 2007. Loss-of-function presenilin mutations in alzheimer disease. talking point on the role of presenilin mutations in alzheimer disease. EMBO Reports 8:141-146. doi: 10.1038/sj.embor.7400897.
14. De Strooper B, Vassar R, Golde T. 2010. The secretases: enzymes with therapeutic potential in alzheimer disease. Nature Reviews. Neurology 6:99-107. doi: 10.1038/nrneurol.2009.218.
15. De Strooper B, Voet T. 2012. Alzheimer’s disease: a protective mutation. Nature 488:38-39. doi: 10.1038/488038a.
16. Del Prete D, Lombino F, Liu X, D’Adamio L. 2014. APP is cleaved by Bace1 in pre-synaptic vesicles and establishes a pre-synaptic interactome, via its intracellular domain, with molecular complexes that regulate pre-synaptic vesicles functions. PloS One 9:e108576. doi: 10.1371/journal.pone.0108576.
17. Ferreira IL, Bajouco LM, Mota SI, Auberson YP, Oliveira CR, Rego AC. 2012. Amyloid beta peptide 1-42 disturbs intracellular calcium homeostasis through activation of GluN2B-containing n-methyl-d-aspartate receptors in cortical cultures. Cell Calcium 51:95-106. doi: 10.1016/j.ceca.2011.11.008.
18. Fogel H, Frere S, Segev O, Bharill S, Shapira I, Gazit N, O’Malley T, Slomowitz E, Berdichevsky Y, Walsh DM, Isacoff EY, Hirsch JA, Slutsky I. 2014. APP homodimers transduce an amyloid-beta-mediated increase in release probability at excitatory synapses. Cell Reports 7:1560-1576. doi: 10.1016/j.celrep.2014.04.024.
19. Garringer HJ, Murrell J, D’Adamio L, Ghetti B, Vidal R. 2010. Modeling familial british and danish dementia. Brain Structure & Function 214:235-244. doi: 10.1007/s00429-009-0221-9.
20. Gervais FG, Xu D, Robertson GS, Vaillancourt JP, Zhu Y, Huang J, LeBlanc A, Smith D, Rigby M, Shearman MS, Clarke EE, Zheng H, Van Der Ploeg LHT, Ruffolo SC, Thornberry NA, Xanthoudakis S, Zamboni RJ, Roy S, Nicholson DW. 1999. Involvement of caspases in proteolytic cleavage of alzheimer’s amyloid-beta precursorprotein and amyloidogenic a peptide formationn. Cell 97:395-406. doi: 10.1016/S0092-8674(00)80748-5.
21. Giliberto L, Zhou D, Weldon R, Tamagno E, De Luca P, Tabaton M, D’Adamio L. 2008. Evidence that the amyloid beta precursor protein-intracellular domain lowers the stress threshold of neurons and has a "regulated" transcriptional role. Molecular Neurodegeneration 3:12. doi: 10.1186/1750-1326-3-12.
22. Giliberto L, d’Abramo C, Acker CM, Davies P, D’Adamio L. 2010. Transgenic expression of the amyloid-beta precursor protein-intracellular domain does not induce alzheimer’s disease-like traits in vivo. PloS One 5:e11609. doi: 10.1371/journal.pone.0011609.
23. Groemer TW, Thiel CS, Holt M, Riedel D, Hua Y, Hüve J, Wilhelm BG, Klingauf J. 2011. Amyloid precursor protein is trafficked and secreted via synaptic vesicles. PloS One 6:e18754. doi: 10.1371/journal.pone.0018754.
24. Gu Z, Liu W, Yan Z. 2009. {beta}-amyloid impairs AMPA receptor trafficking and function by reducing Ca2+/calmodulin-dependent protein kinase II synaptic distribution. The Journal of Biological Chemistry 284:10639-10649. doi: 10.1074/jbc.M806508200.
25. Guo Q, Li H, Gaddam SS, Justice NJ, Robertson CS, Zheng H. 2012. Amyloid precursor protein revisited: neuron- specific expression and highly stable nature of soluble derivatives. The Journal of Biological Chemistry 287:2437-2445. doi: 10.1074/jbc.M111.315051.
26. Hamid R, Kilger E, Willem M, Vassallo N, Kostka M, Bornhövd C, Reichert AS, Kretzschmar HA, Haass C, Herms J. 2007. Amyloid precursor protein intracellular domain modulates cellular calcium homeostasis and ATP content. Journal of Neurochemistry 102:1264-1275. doi: 10.1111/j.1471-4159.2007.04627.x.
27. Heber S, Herms J, Gajic V, Hainfellner J, Aguzzi A, Rülicke T, von Kretzschmar H, von Koch C, Sisodia S, Tremml P, Lipp HP, Wolfer DP, Müller U. 2000. Mice with combined gene knock-outs reveal essential and partially redundant functions of amyloid precursor protein family members. The Journal of Neuroscience 20:7951-7963.
28. Herms J, Anliker B, Heber S, Ring S, Fuhrmann M, Kretzschmar H, Sisodia S, Müller U. 2004. Cortical dysplasia resembling human type 2 lissencephaly in mice lacking all three APP family members. The EMBO Journal 23:4106-4115. doi: 10.1038/sj.emboj.7600390.
29. Hick M, Herrmann U, Weyer SW, Mallm JP, Tschäpe JA, Borgers M, Mercken M, Roth FC, Draguhn A, Slomianka L, Wolfer DP, Korte M, Müller UC. 2015. Acute function of secreted amyloid precursor protein fragment APPsalpha in synaptic plasticity. Acta Neuropathologica 129:21-37. doi: 10.1007/s00401-014-1368-x.
30. Hsieh H, Boehm J, Sato C, Iwatsubo T, Tomita T, Sisodia S, Malinow R. 2006. AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron 52:831-843. doi: 10.1016/j.neuron.2006.10.035.
31. Jonsson T, Atwal JK, Steinberg S, Snaedal J, Jonsson PV, Bjornsson S, Stefansson H, Sulem P, Gudbjartsson D, Maloney J, Hoyte K, Gustafson A, Liu Y, Lu Y, Bhangale T, Graham RR, Huttenlocher J, Bjornsdottir G, Andreassen OA, Jönsson EG, Palotie A, Behrens TW, Magnusson OT, Kong A, Thorsteinsdottir U, Watts RJ, Stefansson K. 2012. A mutation in APP protects against alzheimer’s disease and age-related cognitive decline. Nature 488:96-99. doi: 10.1038/nature11283.
32. Kim HS, Kim EM, Lee JP, Park CH, Kim S, Seo JH, Chang KA, Yu E, Jeong SJ, Chong YH, Suh YH. 2003. C-terminal fragments of amyloid precursor protein exert neurotoxicity by inducing glycogen synthase kinase-3beta expression. FASEB Journal . 17:1951-1953. doi: 10.1096/fj.03-0106fje.
33. Kohli BM, Pflieger D, Mueller LN, Carbonetti G, Aebersold R, Nitsch RM, Konietzko U. 2012. Interactome of the amyloid precursor protein APP in brain reveals a protein network involved in synaptic vesicle turnover and a close association with synaptotagmin-1. Journal of Proteome Research 11:4075-4090. doi: 10.1021/pr300123g.
34. Korte M, Herrmann U, Zhang X, Draguhn A. 2012. The role of APP and APLP for synaptic transmission, plasticity, and network function: lessons from genetic mouse models. Experimental Brain Research 217:435-440. doi: 10.1007/s00221-011-2894-6.
35. Lassek M, Weingarten J, Einsfelder U, Brendel P, Müller U, Volknandt W. 2013. Amyloid precursor proteins are constituents of the presynaptic active zone. Journal of Neurochemistry 127:48-56. doi: 10.1111/jnc.12358.
36. Lassek M, Weingarten J, Acker-Palmer A, Bajjalieh S, Muller U, Volknandt W. 2014. Amyloid precursor protein knockout diminishes synaptic vesicle proteins at the presynaptic active zone in mouse brain. Current Alzheimer Research 11:971-980. doi: 10.2174/1567205011666141107152458.
37. Leissring MA, Murphy MP, Mead TR, Akbari Y, Sugarman MC, Jannatipour M, Anliker B, Müller U, Saftig P, De Strooper B, Wolfe MS, Golde TE, LaFerla FM. 2002. A physiologic signaling role for the gamma -secretase- derived intracellular fragment of. Proceedings of the National Academy of Sciences of the United States of America 99:4697-4702. doi: 10.1073/pnas.072033799.
38. Li S, Hong S, Shepardson NE, Walsh DM, Shankar GM, Selkoe D. 2009. Soluble oligomers of amyloid beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron 62:788-801. doi: 10.1016/j.neuron.2009.05.012.
39. Li H, Wang Z, Wang B, Guo Q, Dolios G, Tabuchi K, Hammer RE, Südhof TC, Wang R, Zheng H. 2010. Genetic dissection of the amyloid precursor protein in developmental function and amyloid pathogenesis. The Journal of Biological Chemistry 285:30598-30605. doi: 10.1074/jbc.M110.137729.
40. Liu Q, Zerbinatti CV, Zhang J, Hoe HS, Wang B, Cole SL, Herz J, Muglia L, Bu G. 2007. Amyloid precursor protein regulates brain apolipoprotein e and cholesterol metabolism through lipoprotein receptor LRP1. Neuron 56:66-78. doi: 10.1016/j.neuron.2007.08.008.
41. Lu DC, Rabizadeh S, Chandra S, Shayya RF, Ellerby LM, Ye X, Salvesen GS, Koo EH, Bredesen DE. 2000. A second cytotoxic proteolytic peptide derived from amyloid beta-protein precursor. Nature Medicine 6:397-404. doi: 10.1038/74656.
42. Lundgren JL, Ahmed S, Schedin-Weiss S, Gouras GK, Winblad B, Tjernberg LO, Frykman S. 2015. ADAM10 and BACE1 are localized to synaptic vesicles. Journal of Neurochemistry 135. doi: 10.1111/jnc.13287.
43. Madeira A, Pommet JM, Prochiantz A, Allinquant B. 2005. SET protein (TAF1beta, I2PP2A) is involved in neuronal apoptosis induced by an amyloid precursor protein cytoplasmic subdomain. FASEB Journal 19:1905-1907. doi: 10.1096/fj.05-3839fje.
44. Marcello E, Epis R, Saraceno C, Di Luca M. 2012. Synaptic dysfunction in alzheimer’s disease. Advances in Experimental Medicine and Biology 970:573-601. doi: 10.1007/978-3-7091-0932-8_25.
45. Matsuda S, Giliberto L, Matsuda Y, Davies P, McGowan E, Pickford F, Ghiso J, Frangione B, D’Adamio L. 2005. The familial dementia BRI2 gene binds the alzheimer gene amyloid-beta precursor protein and inhibits amyloid- beta production. The Journal of Biological Chemistry 280:28912-28916. doi: 10.1074/jbc.C500217200.
46. Matsuda S, Giliberto L, Matsuda Y, McGowan EM, D’Adamio L. 2008. BRI2 inhibits amyloid beta-peptide precursor protein processing by interfering with the docking of secretases to the substrate. The Journal of Neuroscience 28:8668-8676. doi: 10.1523/JNEUROSCI.2094-08.2008.
47. Matsuda S, Matsuda Y, D’Adamio L. 2009. BRI3 inhibits amyloid precursor protein processing in a mechanistically distinct manner from its homologue dementia gene BRI2. The Journal of Biological Chemistry 284:15815-15825. doi: 10.1074/jbc.M109.006403.
48. McMahon HT, Boucrot E. 2011. Molecular mechanism and physiological functions of clathrin-mediated endocytosis. Nature Reviews Molecular Cell Biology 12:517-533. doi: 10.1038/nrm3151.
49. Milosch N, Tanriöver G, Kundu A, Rami A, Franç ois JC, Baumkötter F, Weyer SW, Samanta A, Jäschke A, Brod F, Buchholz CJ, Kins S, Behl C, Müller UC, Kögel D. 2014. Holo-APP and g-protein-mediated signaling are required for sAPPalpha-induced activation of the akt survival pathway. Cell Death & Disease 5:e1391. doi: 10.1038/cddis.2014.352.
50. Mota SI, Ferreira IL, Rego AC. 2014. Dysfunctional synapse in alzheimer’s disease - a focus on NMDA receptors. Neuropharmacology 76:16-26. doi: 10.1016/j.neuropharm.2013.08.013.
51. Mucke L, Selkoe DJ. 2012. Neurotoxicity of amyloid beta-protein: synaptic and network dysfunction. Cold Spring Harbor Perspectives in Medicine 2:a006338. doi: 10.1101/cshperspect.a006338.
52. Müller UC, Zheng H. 2012. Physiological functions of APP family proteins. Cold Spring Harbor Perspectives in Medicine 2:a006288. doi: 10.1101/cshperspect.a006288.
53. Neve RL, Boyce FM, McPhie DL, Greenan J, Oster-Granite ML. 1996. Transgenic mice expressing APP-C100 in the brain. Neurobiology of Aging 17:191-203. doi: 10.1016/0197-4580(95)02074-8.
54. Neve RL, Robakis NK. 1998. Alzheimer’s disease: a re-examination of the amyloid hypothesis. Trends in Neurosciences 21:15-19. doi: 10.1016/S0166-2236(97)01168-5.
55. Nikolaev A, McLaughlin T, O’Leary DD, Tessier-Lavigne M. 2009. APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature 457:981-989. doi: 10.1038/nature07767.
56. Norstrom EM, Zhang C, Tanzi R, Sisodia SS. 2010. Identification of NEEP21 as a beta-amyloid precursor protein- interacting protein in vivo that modulates amyloidogenic processing in vitro. The Journal of Neuroscience 30:15677-15685. doi: 10.1523/JNEUROSCI.4464-10.2010.
57. O’Connell BC, Harper JW. 2007. Ubiquitin proteasome system (uPS): what can chromatin do for you? Current Opinion in Cell Biology 19:206-214. doi: 10.1016/j.ceb.2007.02.014.
58. Octave JN, Pierrot N, Ferao Santos S, Nalivaeva NN, Turner AJ. 2013. From synaptic spines to nuclear signaling: nuclear and synaptic actions of the amyloid precursor protein. Journal of Neurochemistry 126:183-190. doi: 10.1111/jnc.12239.
59. Oster-Granite ML, McPhie DL, Greenan J, Neve RL. 1996. Age-dependent neuronal and synaptic degeneration in mice transgenic for the c terminus of the amyloid precursor protein. The Journal of Neuroscience 16:6732-6741.
60. Parameshwaran K, Dhanasekaran M, Suppiramaniam V. 2008. Amyloid beta peptides and glutamatergic synaptic dysregulation. Experimental Neurology 210:7-13. doi: 10.1016/j.expneurol.2007.10.008.
61. Pardossi-Piquard R, Petit A, Kawarai T, Sunyach C, Alves da Costa C, Vincent B, Ring S, D’Adamio L, Shen J, Müller U, St George Hyslop P, Checler F. 2005. Presenilin-dependent transcriptional control of the abeta- degrading enzyme neprilysin by intracellular domains of betaAPP and APLP. Neuron 46:541-554. doi: 10.1016/j.neuron.2005.04.008.
62. Passer B, Pellegrini L, Russo C, Siegel RM, Lenardo MJ, Schettini G, Bachmann M, Tabaton M, D’Adamio L. 2000. Generation of an apoptotic intracellular peptide by gamma-secretase cleavage of alzheimer’s amyloid beta protein precursor. Journal of Alzheimer’s Disease : JAD 2:289-301.
63. Pellegrini L, Passer BJ, Tabaton M, Ganjei JK, D’Adamio L. 1999. Alternative, non-secretase processing of alzheimer’s -amyloid precursor protein during apoptosis by caspase-6 and -8. Journal of Biological Chemistry 274:21011-21016. doi: 10.1074/jbc.274.30.21011.
64. Priller C, Bauer T, Mitteregger G, Krebs B, Kretzschmar HA, Herms J. 2006. Synapse formation and function is modulated by the amyloid precursor protein. The Journal of Neuroscience 26:7212-7221. doi: 10.1523/JNEUROSCI.1450-06.2006.
65. Puzzo D, Privitera L, Leznik E, Fà M, Staniszewski A, Palmeri A, Arancio O. 2008. Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus. The Journal of Neuroscience 28:14537-14545. doi: 10.1523/JNEUROSCI.2692-08.2008.
66. Puzzo D, Arancio O. 2013. Amyloid-beta peptide: dr. jekyll or mr. hyde? Journal of Alzheimer’s Disease 33:S111-120. doi: 10.3233/JAD-2012-129033.
67. Randall AD, Witton J, Booth C, Hynes-Allen A, Brown JT. 2010. The functional neurophysiology of the amyloid precursor protein (aPP) processing pathway. Neuropharmacology 59:243-267. doi: 10.1016/j.neuropharm.2010.02.011.
68. Rizzoli SO. 2014. Synaptic vesicle recycling: steps and principles. The EMBO Journal 33:788-822. doi: 10.1002/embj.201386357.
69. Roberson ED, Halabisky B, Yoo JW, Yao J, Chin J, Yan F, Wu T, Hamto P, Devidze N, Yu GQ, Palop JJ, Noebels JL, Mucke L. 2011. Amyloid-beta/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of alzheimer’s disease. The Journal of Neuroscience 31:700-711. doi: 10.1523/JNEUROSCI.4152-10.2011.
70. Royle SJ, Lagnado L. 2010. Clathrin-mediated endocytosis at the synaptic terminal: bridging the gap between physiology and molecules. Traffic 11:1489-1497. doi: 10.1111/j.1600-0854.2010.01104.x.
71. Scheinfeld MH, Ghersi E, Laky K, Fowlkes BJ, D’Adamio L. 2002. Processing of beta-amyloid precursor-like protein-1 and -2 by gamma-secretase regulates transcription. The Journal of Biological Chemistry 277:44195-44201. doi: 10.1074/jbc.M208110200.
72. Scheinfeld MH, Matsuda S, D’Adamio L. 2003. JNK-interacting protein-1 promotes transcription of a beta protein precursor but not a beta precursor-like proteins, mechanistically different than Fe65. Proceedings of the National Academy of Sciences of the United States of America 100:1729-1734. doi: 10.1073/pnas.0437908100.
73. Selkoe D, Kopan R. 2003. Notch and presenilin: regulated intramembrane proteolysis links development and degeneration. Annual Review of Neuroscience 26:565-597. doi: 10.1146/annurev.neuro.26.041002.131334.
74. Shankar GM, Bloodgood BL, Townsend M, Walsh DM, Selkoe DJ, Sabatini BL. 2007. Natural oligomers of the alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. The Journal of Neuroscience 27:2866-2875. doi: 10.1523/JNEUROSCI.4970-06.2007.
75. Sisodia SS, St George-Hyslop PH. 2002. Gamma-secretase, notch, abeta and alzheimer’s disease: where do the presenilins fit in? Nature Reviews. Neuroscience 3:281-290. doi: 10.1038/nrn785.
76. Sivanesan S, Tan A, Rajadas J. 2013. Pathogenesis of abeta oligomers in synaptic failure. Current Alzheimer Research 10:316-323. doi: 10.2174/1567205011310030011.
77. Südhof TC, Rizo J. 2011. Synaptic vesicle exocytosis. Cold Spring Harbor Perspectives in Biology 3. doi: 10.1101/cshperspect.a005637.
78. Südhof TC. 2012. The presynaptic active zone. Neuron 75:11-25. doi: 10.1016/j.neuron.2012.06.012.
79. Südhof TC. 2013. Neurotransmitter release: the last millisecond in the life of a synaptic vesicle. Neuron 80:675-690. doi: 10.1016/j.neuron.2013.10.022.
80. Talani G, Biggio G, Sanna E. 2011. Enhanced sensitivity to ethanol-induced inhibition of LTP in CA1 pyramidal neurons of socially isolated C57BL/6J mice: role of neurosteroids. Frontiers in Endocrinology 2:56. doi: 10.3389/fendo.2011.00056.
81. Tamayev R, Akpan N, Arancio O, Troy CM, D’Adamio L. 2012a. Caspase-9 mediates synaptic plasticity and memory deficits of danish dementia knock-in mice: caspase-9 inhibition provides therapeutic protection. Molecular Neurodegeneration 7:60. doi: 10.1186/1750-1326-7-60.
82. Tamayev R, D’Adamio L. 2012b. Inhibition of g-secretase worsens memory deficits in a genetically congruous mouse model of danish dementia. Molecular Neurodegeneration 7:19. doi: 10.1186/1750-1326-7-19.
83. Tamayev R, Matsuda S, Arancio O, D’Adamio L. 2012c. Beta- but not gamma-secretase proteolysis of APP causes synaptic and memory deficits in a mouse model of dementia. EMBO Molecular Medicine 4:171-179. doi: 10.1002/emmm.201100195.
84. Tanzi RE. 2012. The genetics of alzheimer disease. Cold Spring Harbor Perspectives in Medicine 2. doi: 10.1101/cshperspect.a006296.
85. Turner PR, O’Connor K, Tate WP, Abraham WC. 2003. Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory. Progress in Neurobiology 70:1-32. doi: 10.1016/S0301-0082(03)00089-3.
86. Um JW, Nygaard HB, Heiss JK, Kostylev MA, Stagi M, Vortmeyer A, Wisniewski T, Gunther EC, Strittmatter SM. 2012. Alzheimer amyloid-beta oligomer bound to postsynaptic prion protein activates fyn to impair neurons. Nature Neuroscience 15:1227-1235. doi: 10.1038/nn.3178.
87. Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, Teplow DB, Ross S, Amarante P, Loeloff R, Luo Y, Fisher S, Fuller J, Edenson S, Lile J, Jarosinski MA, Biere AL, Curran E, Burgess T, Louis JC, Collins F, Treanor J, Rogers G, Citron M. 1999. Beta-secretase cleavage of alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286:735-741. doi: 10.1126/science.286.5440.735.
88. Venkitaramani DV, Chin J, Netzer WJ, Gouras GK, Lesne S, Malinow R, Lombroso PJ. 2007. Beta-amyloid modulation of synaptic transmission and plasticity. The Journal of Neuroscience 27:11832-11837. doi: 10.1523/JNEUROSCI.3478-07.2007.
89. Vidal R, Frangione B, Rostagno A, Mead S, Révész T, Plant G, Ghiso J. 1999. A stop-codon mutation in the BRI gene associated with familial british dementia. Nature 399:776-781. doi: 10.1038/21637.
90. Vidal R, Revesz T, Rostagno A, Kim E, Holton JL, Bek T, Bojsen-Møller M, Braendgaard H, Plant G, Ghiso J, Frangione B. 2000. A decamer duplication in the 3’ region of the BRI gene originates an amyloid peptide that is associated with dementia in a danish kindred. Proceedings of the National Academy of Sciences of the United States of America 97:4920-4925. doi: 10.1073/pnas.080076097.
91. von Koch CS, Zheng H, Chen H, Trumbauer M, Thinakaran G, van der Ploeg LHT, Price DL, Sisodia SS. 1997. Generation of APLP2 KO mice and early postnatal lethality in APLP2/APP double KO mice. Neurobiology of Aging 18:661-669. doi: 10.1016/S0197-4580(97)00151-6.
92. von Rotz RC, Kohli BM, Bosset J, Meier M, Suzuki T, Nitsch RM, Konietzko U. 2004. The APP intracellular domain forms nuclear multiprotein complexes and regulates the transcription of its own precursor. Journal of Cell Science 117:4435-4448. doi: 10.1242/jcs.01323.
93. Wang P, Yang G, Mosier DR, Chang P, Zaidi T, Gong YD, Zhao NM, Dominguez B, Lee KF, Gan WB, Zheng H. 2005. Defective neuromuscular synapses in mice lacking amyloid precursor protein (aPP) and APP-like protein 2. The Journal of Neuroscience 25:1219-1225. doi: 10.1523/JNEUROSCI.4660-04.2005.
94. Watanabe T, Sukegawa J, Sukegawa I, Tomita S, Iijima Ko-ichi, Oguchi S, Suzuki T, Nairn AC, Greengard P. 1999. A 127-kDa protein (uV-DDB) binds to the cytoplasmic domain of the alzheimer’s amyloid precursor protein. Journal of Neurochemistry 72:549-556. doi: 10.1046/j.1471-4159.1999.0720549.x.
95. Weidemann A, Paliga K, Durrwang U, Reinhard FBM, Schuckert O, Evin G, Masters CL. 1999. Proteolytic processing of the alzheimer’s disease amyloid precursor protein within its cytoplasmic domain by caspase-like proteases. Journal of Biological Chemistry 274:5823-5829. doi: 10.1074/jbc.274.9.5823.
96. Wilhelm BG, Mandad S, Truckenbrodt S, Kröhnert K, Schäfer C, Rammner B, Koo SJ, Claßen GA, Krauss M, Haucke V, Urlaub H, Rizzoli SO. 2014. Composition of isolated synaptic boutons reveals the amounts of vesicle trafficking proteins. Science 344:1023-1028. doi: 10.1126/science.1252884.
97. Willem M, Tahirovic S, Busche MA, Ovsepian SV, Chafai M, Kootar S, Hornburg D, Evans LD, Moore S, Daria A, Hampel H, Müller V, Giudici C, Nuscher B, Wenninger-Weinzierl A, Kremmer E, Heneka MT, Thal DR, Giedraitis V, Lannfelt L, Müller U, Livesey FJ, Meissner F, Herms J, Konnerth A, Marie H, Haass C. 2015. h-secretase processing of APP inhibits neuronal activity in the hippocampus. Nature 526:443-447. doi: 10.1038/nature14864.
98. Wu B, Yamaguchi H, Lai FA, Shen J. 2013. Presenilins regulate calcium homeostasis and presynaptic function via ryanodine receptors in hippocampal neurons. Proceedings of the National Academy of Sciences of the United States of America 110:15091-15096. doi: 10.1073/pnas.1304171110.
99. Xia D, Watanabe H, Wu B, Lee SH, Li Y, Tsvetkov E, Bolshakov VY, Shen J, Kelleher RJ. 2015. Presenilin-1 knockin mice reveal loss-of-function mechanism for familial alzheimer’s disease. Neuron 85:967-981. doi: 10.1016/j.neuron.2015.02.010.
100. Xu J, Pang ZP, Shin OH, Südhof TC. 2009. Synaptotagmin-1 functions as a Ca2+ sensor for spontaneous release. Nature Neuroscience 12:759-766. doi: 10.1038/nn.2320.
101. Yang G, Gong YD, Gong K, Jiang WL, Kwon E, Wang P, Zheng H, Zhang XF, Gan WB, Zhao NM. 2005. Reduced synaptic vesicle density and active zone size in mice lacking amyloid precursor protein (aPP) and APP-like protein 2. Neuroscience Letters 384:66-71. doi: 10.1016/j.neulet.2005.04.040.
102. Zhang C, Wu B, Beglopoulos V, Wines-Samuelson M, Zhang D, Dragatsis I, Südhof TC, Shen J. 2009. Presenilins are essential for regulating neurotransmitter release. Nature 460:632-636. doi: 10.1038/nature08177.
103. Zucker RS, Regehr WG. 2002. Short-term synaptic plasticity. Annual Review of Physiology 64:355-405. doi: 10.1146/annurev.physiol.64.092501.114547.